Teva Pharmaceutical Industries Limited to acquire Barr Pharmaceuticals Inc

Tuesday, July 22, 2008; Posted: 04:40 AM

7 Stocks You Need To Know For Tomorrow -- Free Newsletter

Jul 22, 2008 (M2 EQUITYBITES via COMTEX) -- TEVA | Quote | Chart | News | PowerRating -- Industrial Info Resources (Sugar Land, Texas) declared on 21 July that generic company Teva Pharmaceutical Industries Limited (Jerusalem, Israel) has entered into an agreement to acquire Barr Pharmaceuticals Inc (NYSE:BRL) (Woodcliff Lake, New Jersey), a generic company, for a purchase price of USD7.46bn.

Teva stated that if the two companies had been operating as one in 2007, the combined revenue would have been close to USD12bn.

The transaction is expected to close by the end of 2008. Teva Pharmaceutical Industries Limited, at the end of the acquisition, will have operations in more than 60 countries.

Comments on this story may be sent to admin@m2.com

For full details on Barr Laboratories Inc (BRL) click here. Barr Laboratories Inc (BRL) has Short Term PowerRatings of 2. Details on Barr Laboratories Inc (BRL) Short Term PowerRatings is available at This Link.

Morning Coffee with TradingMarkets -- Free Newsletter

More News: Market Updates | Stock Alerts | All Trading News | Stock Index

Archives

Feedback

Email Article Link

Close X

RELATED SITES

Please call 1-213-955-5858 ext. 1

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.